TRV GP IV’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$74.5M Hold
6,073,958
45.63% 2
2025
Q1
$66.9M Buy
+6,073,958
New +$66.9M 72.02% 1